Literature DB >> 8279650

High doses of penicillin decreases [3H]flunitrazepam binding sites in rat neuron primary culture.

H Shiraishi1, M Ito, T Go, H Mikawa.   

Abstract

Penicillin (PC) neurotoxicity (convulsions and encephalopathy) is considered to be due to GABAergic inhibition. The effects of penicillin G(PCG) on [3H]flunitrazepam (FNZ) binding in rat neuron-enriched primary cultures was examined to assess the role of the benzodiazepine (BDZ) receptor in the neurotoxicity. PCG application for 24 h induced a significant decrease in [3H]FNZ binding activity at 10(-3) M, and a decrease in available receptor number (Bmax) at 10(-2) M, without obvious cell damage. Pre-application of the BDZ receptor antagonist, Ro-15-1788, prevented the PC-induced decrease in [3H]FNZ binding activity. Therefore, PC seems to reduce the number of BDZ receptors through a direct effect on this receptor, which is a part of the major inhibitory system in mammalian brain; the GABAergic macromolecular receptor complex. This decrease in BDZ receptors may play a role in PC-induced neurotoxicity, especially encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279650     DOI: 10.1016/0387-7604(93)90121-n

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

Review 1.  The Gut-Brain Axis, BDNF, NMDA and CNS Disorders.

Authors:  Raeesah Maqsood; Trevor W Stone
Journal:  Neurochem Res       Date:  2016-08-23       Impact factor: 3.996

2.  Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites.

Authors:  A V Kalueff
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

Review 3.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

4.  Antimicrobial-induced cognitive side effects.

Authors:  Amanda Warstler; Jennifer Bean
Journal:  Ment Health Clin       Date:  2016-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.